SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutics for retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and uveitis, KSI-201 for resistant wet AMD, and KSI-401 for dry AMD. The company was founded by Stephen A. Charles and Victor Perlroth in 2009 and is headquartered in Palo Alto, CA.

Kodiak Sciences Inc

Kodiaks Phase 3 DAYBREAK study met its primary endpoints for Zenkuda and tabirafusp-ted in wet AMD; Zenkuda also showed six-month dosing durability for many patients, and Kodiak plans an FDA filing. Traders are celebrating the results and discussing a possible short squeeze, while others warn that the sharp rally may invite profit-taking and point to remaining FDA, commercial, and financing risks.

Hedera is a decentralized public network where developers can build secure, fair applications with near real-time consensus. The platform is owned and governed by a council of global innovators including Avery Dennison, Boeing, Deutsche Telekom, DLA Piper, FIS (WorldPay), Google, IBM, LG Electronics, Magalu, Nomura, Swirlds, Tata Communications, University College London (UCL), Wipro, and Zain Group.   The Hedera Consensus Service (HCS) acts as a trust layer for any application or permissioned network and allows for the creation of an immutable and verifiable log of messages. Application messages are submitted to the Hedera network for consensus, given a trusted timestamp, and fairly ordered. Use HCS to track assets across a supply chain, create auditable logs of events in an advertising platform, or even use it as a decentralized ordering service.

Hedera Hashgraph

HBARs sharp rally and heavy volume are driving attention, with traders pointing to IBM-related enterprise AI and digital-identity developments as a possible catalyst. Others attribute the move to a technical breakout, short covering, or broader crypto momentum, while questioning whether it can hold and noting uncertainty about a clear trigger.

London-based Quant Network is set to revolutionise blockchain technology with the development of their blockchain operating system Overledger. The experienced team are determined to fulfil the original vision of the internet by creating an open trusted network for people, machines, and data to operate securely and safely.  Overledger -the first interoperable blockchain operating system that facilitates internet-scale development of decentralised, multi-chain applications. Overledger has the ability to unlock and distribute value and applications across current and future blockchains. It is an agnostic platform that connects the world's networks to blockchains and ensures you're not limited to any single a vendor or technology. Overledger is the only platform that facilitates the development of internet-scales development of decentralised, multi-chain applications.

Quant

Quants reported selection by The Clearing House for its on-chain money initiative is the dominant catalyst, with traders viewing it as a major institutional-adoption signal for the bank-focused interoperability network. Bulls cite limited token supply and potential demand, while skeptics question whether the deal creates meaningful demand for QNT itself; the sharp rally has also prompted profit-taking and volatility concerns.

MongoDB, Inc. engages in the development and provision of a general-purpose database platform. The firm's products include MongoDB Enterprise Advanced, MongoDB Atlas, and Community Server. It also offers professional services including consulting and training. The company was founded by Eliot Horowitz, Dwight A. Merriman, Kevin P. Ryan, and Geir Magnusson Jr. in 2007 and is headquartered in New York, NY.

MongoDB Inc - Ordinary Shares - Class A

MongoDB Inc

MongoDB shares are under pressure after CEO CJ Desai stepped down to join Meta, with former CEO Dev Ittycheria returning as interim leader and the company reaffirming its guidance. Traders are split between viewing the abrupt change ahead of investor day as a source of leadership and execution uncertainty and calling the selloff an overreaction because the business outlook remains intact.

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Ocular Therapeutix Inc

OCUL is under pressure as traders weigh Kodiaks positive late-stage wet AMD results and the competitive threat to AXPAXLI. Some see the selloff as an overreaction, arguing AXPAXLI may offer longer dosing intervals and has an FDA-aligned NDA path; others question its competitive edge and market potential.

Cleveland-Cliffs, Inc. is a flat-rolled steel company, which engages in provision of iron ore pellets to the North American steel industry. It focuses on the production of metallic and coke, iron making, steelmaking, rolling and finishing, and downstream tubular components, stamping, and tooling. It operates through the Steelmaking and Other Businesses segments. The company was founded in 1847 and is headquartered in Cleveland, OH.

Cleveland-Cliffs Inc

Discussion centers on the proposed Iowa steel plant linked to Mesabi Metallics, which traders see as a potential future competitor and a possible complication for CLFs Minnesota iron-ore leases. Some argue the project is years away and faces financing and permitting hurdles; others point to Nucors weaker forecast as a possible sector read-through for the sharp selloff, while disputing that the plant alone explains it.

Amprius Technologies, Inc. engages in the development, manufacture, and market of lithium-ion batteries for mobility applications, including the aviation, electric vehicle and light electric vehicle industries. It operates through the following geographical segments: North America, EMEA, and Asia Pacific. The company was founded by Mark C. Platshon in 2008 and headquartered in Fremont, CA.

Amprius Technologies Inc

Amprius federal defense grant to convert a domestic EV battery line for high-energy-density drone cells is driving attention. Traders welcomed the government backing but were frustrated that the initial rally faded, debating profit-taking and broader market weakness against the companys longer-term manufacturing prospects.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. The firm operates through the following geographical segments: United States and International. It offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

A sharp slowdown in advertising growth and weak guidance, compounded by S&P 500 removal and index-related selling, are weighing on TTD as shares hit multi-year lows. Traders largely criticize management and the CEOs compensation amid concerns about competition and growth, while some dip buyers point to the companys cash position and heavily shorted stock as reasons for optimism.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: QNX, Secure Communications, and Licensing. The QNX segment includes development of safe and reliable software for embedded systems across technology-driven industries. The Secure Communications segment delivers operational resiliency with a government-grade portfolio of secure, certified solutions for mobile fortification, critical communications and crisis management. The Licensing segment focuses on management and monetization of the firm's global patent portfolio. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerrys stronger-than-expected quarterly results, record QNX growth, raised full-year outlook and first Alloy Kore automotive design win are driving attention. Bulls see evidence of a software-growth turnaround, while skeptics cite weaker Secure Communications guidance, the long wait for Alloy Kore royalties and valuation concerns to explain the volatile share-price reaction.

ZIM Integrated Shipping Services Ltd. engages in the provision of shipping and logistics services. It offers shipping solutions, including the transportation of out-of-gauge cargo, refrigerated cargo, and dangerous and hazardous cargo. The company was founded on June 7, 1945 and is headquartered in Haifa, Israel.

Zim Integrated Shipping Services Ltd

Israeli government opposition to ZIMs proposed Hapag-Lloyd sale is driving attention, with reports of fresh objections over national security and shipping independence raising uncertainty about approval. Traders are divided: some are selling on deal risk, while others see a failed sale as a chance for stronger standalone earnings and dividends amid elevated freight rates.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$CAPR Negative (78%): shares are pressured because unfavorable FDA briefing language lowers the market-implied probability of approval and raises the risk of a delayed launch, additional studies, and dilutive financing. Full AI impact map, source, and watch-next details: https://nimpact.tech/newsimpact/news/75046901e77bd9d5?utm_source=stocktwits&amp;utm_medium=story_url

Negative stock-price impact for $CAPR with 78% confidence. This is a material negative catalyst for CAPR. Google News confirms that Investing.com carried the headline at the stated time, but the supplied...

NewsImpact

$CAPR: Negative impact - Capricor Therapeutics stock tumbles... | NewsImpact

StockTwits Web

Capricor Therapeutics Inc

Attention centers on Capricors presentation of 24-month HOPE-3 data at the World Muscle Society Congress, which is relevant to the FDAs review of deramiocel for Duchenne muscular dystrophy. Bulls see the delayed-start results as potential support for efficacy and approval, while skeptics question the statistical analysis and emphasize that the FDA decision remains uncertain; short-interest and squeeze speculation also feature prominently.

 Negative (78%): shares are pressured because unfavorable FDA briefing language lowers the market-implied probability of approval and raises the risk of a delayed launch, additional studies, and dilutive financing. Full AI impact map, source, and watch-next details: 